Does this pain device really work? a blinded trial aims to find out

NCT ID NCT07468591

Not yet recruiting Symptom relief Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a newer form of spinal cord stimulation (paresthesia-free SCS) actually reduces chronic pain or if its benefits are just a placebo effect. Ninety adults with severe neuropathic pain will receive both active and placebo stimulation for six weeks each, with a two-week break in between. The goal is to see if the device truly helps with pain, daily activity, and sleep.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: paresthesia-free spinal cord stimulation (device)
What this could lead to: If it works, this could confirm that paresthesia-free spinal cord stimulation is a real, effective treatment for chronic pain, not just a placebo effect.
What could go wrong: This is a small, early-stage trial (90 people) and the results may not apply to everyone. The placebo effect is strong in pain studies, so even a well-designed trial might not show a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN SYNDROME

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.